Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

Autor: Bhatnagar, A, Burton, B, Chakravarthy, U, Eleftheriadis, H, Empeslidis, T, Gale, R, George, S, Habib, M, Kelly, S, Lotery, A, McKibbin, M, Membrey, L, Menon, G, Mushtaq, B, Nicholson, L, Ramu, J, Osoba, O, Patel, J, Prakash, P, Purbrick, R, Ross, A, Stylianides, A, Talks, J, Harding, S, Peto, T, Yeo, S T, Laidlaw, Alistair, Amoaku, Winfried, Hood, Gillian, Hitman, Graham A, Preece, Daniel, Burns, Paul, Walker, Sarah, Mensah, Evelyn, Karia, Niral, Sivaprasad, Sobha ^{a, *}, Prevost, A Toby ^b, Vasconcelos, Joana C ^b, Riddell, Amy ^c, Murphy, Caroline ^c, Kelly, Joanna ^c, Bainbridge, James ^d, Tudor-Edwards, Rhiannon ^e, Hopkins, David ^f, Hykin, Philip ^a

Publikováno v: In The Lancet 3-9 June 2017 389(10085):2193-2203

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pilot randomised controlled trial of face-down positioning following macular hole surgery.

Autor: Lange, C A K¹, Membrey, L², Ahmad, N², Wickham, L², Maclaren, R E², Solebo, L³, Xing, W², Bunce, C², Ezra, E², Charteris, D², Aylward, B², Yorston, D⁴, Gregor, Z², Zambarakji, H⁵, Bainbridge, J W²

Publikováno v: Eye. Feb2012, Vol. 26 Issue 2, p272-277. 6p.

Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT) A Phase 3 Randomized Controlled Trial Presented in part at: Retina Day, American Academy of Ophthalmology Annual Meeting, November 2015, Las Vegas, Nevada

Autor: Jackson, T.L., Desai, R., Simpson, A., Neffendorf, J.E., Petrarca, R., Smith, K., Wittes, J., Lewis, C., Membrey, L., Haynes, R., Costen, M., Steel, D.H.W., Muldrew, A., Chakravarthy, U.

Publikováno v: Jackson, T L, Desai, R, Simpson, A, Neffendorf, J E, Petrarca, R, Smith, K, Wittes, J, Lewis, C, Membrey, L, Haynes, R, Costen, M, Steel, D H W, Muldrew, A & Chakravarthy, U 2016, ' Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT) A Phase 3 Randomized Controlled Trial Presented in part at: Retina Day, American Academy of Ophthalmology Annual Meeting, November 2015, Las Vegas, Nevada. ', Ophthalmology, vol. 123, no. 6, pp. 1287-1296 . https://doi.org/10.1016/j.ophtha.2016.02.028

Purpose To assess the safety and efficacy of epimacular brachytherapy (EMB) for patients with chronic, active, neovascular age-related macular degeneration (AMD). Design Phase 3 randomized controlled trial. Participants Patients (n = 363) with neovas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2607::828fa6a6fbafc257474cb58d38c84557
https://pure.qub.ac.uk/en/publications/epimacular-brachytherapy-for-previously-treated-neovascular-agerelated-macular-degeneration-merlot-a-phase-3-randomized-controlled-trial-presented-in-part-at-retina-day-american-academy-of-ophthalmology-annual-meeting-november-2015-las-vegas-nevada(01b4bbf8-51bd-4946-9325-fc95a366abbf).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.